Coronavirus disease 2019 (COVID-19)
Situation Report - 70
St World Health
^Organization
fS
Data as reported by national authorities by 10:00 CET 30 March 2020
HIGHLIGHTS
• No new countries/territories/areas reported cases of COVID-19 in the past 24
hours.
• WHO has updated the operational planning guidelines to help countries
maintain essential health services during the COVID-19 pandemic. The
document includes a set of immediate actions that countries should consider
at national, regional, and local level to reorganize and maintain access to high-
quality essential health services for all. For more information:
https://www.who.int/publications-detail/covid-19-operational-guidance-for-
maintaining-essential-health-services-during-an-outbreak
SITUATION IN NUMBERS
total (new) cases in last 24 hours
Globally
693 224 confirmed (58 411)
33 106 deaths (3215)
Western Pacific Region
103 775 confirmed (987)
3649 deaths (23)
European Region
392 757 confirmed (31 726)
23 962 deaths (2535)
South-East Asia Region
4084 confirmed (375)
158 deaths (19)
Eastern Mediterranean Region
46 329 confirmed (3552)
2813 deaths (145)
Region of the Americas
142 081 confirmed (21 289)
2457 deaths (484)
African Region
3486 confirmed (482)
60 deaths (09)
WHO RISK ASSESSMENT
Global Level Very High
Figure 1. Countries, territories or areas with reported confirmed cases of COVID-19, 30 March 2020
Countries, areas or territories with COVID-19 cases reported in the last 7 days,
as of 30 March 2020, 10:00 (CET)
Cases reported in the last 7 days
[1] All references lo Kosovo in this document should be understood
to be In the context of the United Nations Security Council
resolution 1244(1999).
Number of cases of Serbia and Kosovo (UNSCR 1 244, 1999)
have been aggregated for visualization purposes.
Data Source- World Health Organization
Map Production ■ WHO Health Emergencies Programme
Not applicable
©World Health Organization 2020, All rights reserved
1001 - 10000
I 10001 - 50000
I >50000
Country, area or territory with no cases reported
in the last 7 days
Country, area or territory without cases
The boundaries and names shown and the designations used on this map do not imply the expression of any
opinion whatsoever on the part of the World Health Organization concerning the legal status of any country,
territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted
and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
SURVEILLANCE
Table 1. Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths. Data as of
30 March 2020*
Reporting Country/
Territory/Area +
Total
confirmed
* cases
Total
confirmed
new cases
Total
deaths
Total
new
deaths
Transmission
classification 9
Days since last
reported case
Western Pacific Region
China
82447
106
3310
4
Local transmission
0
Republic of Korea
9661
78
158
6
Local transmission
0
Australia
3966
0
16
0
Local transmission
1
Malaysia
2470
150
34
7
Local transmission
0
Japan
1866
173
54
2
Local transmission
0
Philippines
1418
343
71
3
Local transmission
0
Singapore
844
42
3
1
Local transmission
0
New Zealand
552
76
1
0
Local transmission
0
Viet Nam
188
9
0
0
Local transmission
0
Brunei Darussalam
126
6
1
0
Local transmission
0
Cambodia
103
1
0
0
Local transmission
0
Mongolia
12
0
0
0
Imported cases only
2
Lao People's
Democratic Republic
8
2
0
0
Local transmission
0
Fiji
5
0
0
0
Local transmission
4
Papua New Guinea
1
0
0
0
Imported cases only
9
Territories"
Guam
56
0
1
0
Local transmission
1
French Polynesia
35
1
0
0
Local transmission
0
New Caledonia
15
0
0
0
Local transmission
2
Northern Mariana
Islands
(Commonwealth of
the)
2
0
0
0
Under investigation
1
European Region
Italy
97689
5217
10781
758
Local transmission
0
Spain
78797
6549
6528
838
Local transmission
0
Germany
57298
4751
455
66
Local transmission
0
France
39642
2497
2602
291
Local transmission
0
The United Kingdom
19526
2433
1228
209
Local transmission
0
Switzerland
14274
1122
257
22
Local transmission
0
Netherlands
10866
1104
771
132
Local transmission
0
Belgium
10836
1702
431
78
Local transmission
0
Turkey
9271
1869
131
23
Local transmission
0
Austria
8813
522
86
18
Local transmission
0
Portugal
5962
792
119
19
Local transmission
0
Israel
4247
382
15
0
Local transmission
0
Norway
4102
257
22
2
Local transmission
0
Sweden
3700
253
110
8
Local transmission
0
Czechia
2829
166
16
5
Local transmission
0
Ireland
2615
200
46
10
Local transmission
0
Denmark
2395
194
72
7
Local transmission
0
Luxembourg
1950
119
21
3
Local transmission
0
Poland
1862
224
22
4
Local transmission
0
Romania
1760
308
40
11
Local transmission
0
Russian Federation
1534
0
10
2
Local transmission
1
Finland
1218
0
11
2
Local transmission
1
Greece
1156
95
38
6
Local transmission
0
Iceland
1020
57
2
0
Local transmission
0
Serbia
741
82
13
3
Local transmission
0
Slovenia
730
39
11
2
Local transmission
0
Croatia
713
56
6
1
Local transmission
0
Estonia
679
39
3
2
Local transmission
0
Lithuania
484
90
7
0
Local transmission
0
Armenia
482
58
3
0
Local transmission
0
Ukraine
480
62
11
2
Local transmission
0
Hungary
447
39
15
2
Local transmission
0
Latvia
376
71
0
0
Local transmission
0
Bulgaria
346
15
8
1
Local transmission
0
Andorra
341
20
6
2
Local transmission
0
Slovakia
336
41
0
0
Local transmission
0
Bosnia and
Herzegovina
325
56
6
0
Local transmission
0
Kazakhstan
294
29
1
0
Under investigation
0
Republic of Moldova
263
32
2
0
Local transmission
0
North Macedonia
259
18
6
2
Local transmission
0
San Marino
229
1
24
2
Local transmission
0
Albania
223
11
10
0
Local transmission
0
Cyprus
214
35
6
1
Local transmission
0
Azerbaijan
190
26
4
0
Local transmission
0
Malta
151
12
0
0
Local transmission
0
Uzbekistan
145
12
2
0
Local transmission
0
Georgia
98
8
0
0
Local transmission
0
Belarus
94
0
0
0
Local transmission
2
Montenegro
85
3
1
0
Local transmission
0
Kyrgyzstan
84
0
0
0
Local transmission
1
Liechtenstein
62
1
0
0
Under investigation
0
Monaco
46
27
0
0
Local transmission
0
Holy See
6
2
0
0
Under investigation
0
Territories”
Faroe Islands
159
4
0
0
Local transmission
0
Kosovo 111
94
3
1
0
Local transmission
0
Gibraltar
65
9
0
0
Local transmission
0
Jersey
63
2
2
1
Local transmission
0
Isle of Man
42
10
0
0
Local transmission
0
Guernsey
39
0
0
0
Local transmission
1
Greenland
10
0
0
0
Under investigation
1
South-East Asia Region
Thailand
1524
136
9
2
Local transmission
0
Indonesia
1285
130
114
12
Local transmission
0
India
1071
92
29
4
Local transmission
0
Sri Lanka
120
14
1
1
Local transmission
0
Bangladesh
49
1
5
0
Local transmission
0
Maldives
17
1
0
0
Local transmission
0
Myanmar
8
0
0
0
Local transmission
1
Nepal
5
0
0
0
Imported cases only
1
Bhutan
4
1
0
0
Imported cases only
0
Timor-Leste
1
0
0
0
Under investigation
9
Eastern Mediterranean Region
Iran (Islamic Republic
of)
38309
2901
2640
123
Local transmission
0
Pakistan
1625
99
18
5
Local transmission
0
Saudi Arabia
1299
96
8
4
Local transmission
0
Qatar
634
44
2
1
Local transmission
0
Egypt
609
33
40
4
Local transmission
0
United Arab Emirates
570
102
3
1
Local transmission
0
Iraq
547
41
42
0
Local transmission
0
Morocco
516
79
27
1
Local transmission
0
Bahrain
515
39
4
0
Local transmission
0
Lebanon
438
26
10
2
Local transmission
0
Tunisia
312
34
8
0
Local transmission
0
Jordan
259
13
3
2
Local transmission
0
Kuwait
255
20
0
0
Local transmission
0
Oman
167
0
0
0
Local transmission
1
Afghanistan
114
0
4
0
Local transmission
1
Djibouti
19
4
0
0
Local transmission
0
Syrian Arab Republic
9
4
1
1
Imported cases only
0
Libya
8
5
0
0
Local transmission
0
Sudan
6
1
2
1
Imported cases only
0
Somalia
3
0
0
0
Imported cases only
3
Territories”
occupied Palestinian
territory
115
11
1
0
Local transmission
0
Region of the Americas
United States of
America
122653
19332
2112
444
Local transmission
0
Canada
5655
898
61
6
Local transmission
0
Brazil
3904
487
114
22
Local transmission
0
Chile
1909
0
6
0
Local transmission
1
Ecuador
1835
12
48
0
Local transmission
0
Panama
901
115
17
3
Local transmission
0
Mexico
848
131
16
4
Local transmission
0
Argentina
745
55
19
2
Local transmission
0
Peru
671
36
11
0
Local transmission
0
Colombia
608
69
6
0
Local transmission
0
Dominican Republic
581
0
20
0
Local transmission
2
Uruguay
303
29
0
0
Local transmission
0
Costa Rica
295
32
2
0
Local transmission
0
Cuba
119
0
3
0
Local transmission
1
Venezuela (Bolivarian
Republic of)
113
0
2
0
Local transmission
1
Honduras
110
43
2
1
Local transmission
0
Trinidad and Tobago
76
2
3
1
Local transmission
0
Bolivia (Plurinational
State of)
74
0
0
0
Local transmission
1
Paraguay
59
3
3
0
Local transmission
0
Guatemala
34
2
1
0
Local transmission
0
Jamaica
32
2
1
0
Local transmission
0
Barbados
26
2
0
0
Local transmission
0
El Salvador
24
5
0
0
Local transmission
0
Haiti
15
7
0
0
Imported cases only
0
Dominica
11
0
0
0
Local transmission
3
Bahamas
10
0
0
0
Local transmission
1
Suriname
8
0
0
0
Imported cases only
2
Antigua and Barbuda
7
0
0
0
Imported cases only
2
Grenada
7
0
0
0
Local transmission
3
Guyana
5
0
1
0
Local transmission
11
Nicaragua
4
0
1
0
Imported cases only
1
Saint Kitts and Nevis
4
2
0
0
Imported cases only
0
Saint Lucia
4
1
0
0
Imported cases only
0
Belize
2
0
0
0
Local transmission
4
Saint Vincent and the
Grenadines
1
0
0
0
Imported cases only
17
Territories**
Martinique
105
12
2
1
Imported cases only
0
Guadeloupe
96
0
2
0
Imported cases only
2
Puerto Rico
64
0
2
0
Imported cases only
3
Aruba
46
0
0
0
Local transmission
1
French Guiana
31
0
0
0
Local transmission
2
Bermuda
22
5
0
0
Local transmission
0
United States Virgin
Islands
22
5
0
0
Imported cases only
0
Cayman Islands
8
0
1
0
Imported cases only
4
Curasao
7
0
1
0
Imported cases only
3
Saint Martin
6
0
0
0
Under investigation
0
Montserrat
5
0
0
0
Imported cases only
2
Saint Barthelemy
5
0
0
0
Under investigation
2
Turks and Caicos
Islands
4
2
0
0
Local transmission
0
Sint Maarten
3
0
0
0
Imported cases only
2
Anguilla
2
0
0
0
Local transmission
3
British Virgin Islands
2
0
0
0
Imported cases only
3
African Region
South Africa
1280
93
1
0
Local transmission
0
Algeria
454
45
29
3
Local transmission
0
Burkina Faso
222
76
3
0
Local transmission
0
Cote d'Ivoire
165
25
0
0
Local transmission
0
Ghana
152
15
5
1
Local transmission
0
Senegal
142
23
0
0
Local transmission
0
Cameroon
113
22
2
0
Local transmission
0
Mauritius
102
0
2
0
Local transmission
1
Democratic Republic
of the Congo
81
13
8
2
Local transmission
0
Rwanda
70
10
0
0
Local transmission
0
Nigeria
65
0
1
0
Local transmission
3
Madagascar
37
11
0
0
Imported cases only
0
Uganda
33
19
0
0
Local transmission
0
Togo
28
0
1
1
Local transmission
0
Kenya
25
0
1
0
Local transmission
5
Ethiopia
21
5
0
0
Local transmission
0
Niger
20
10
3
2
Local transmission
0
Congo
19
0
0
0
Imported cases only
2
Mali
18
0
0
0
Local transmission
1
Guinea
16
8
0
0
Imported cases only
0
Zambia
16
0
0
0
Local transmission
1
United Republic of
14
0
0
0
Under investigation
1
Tanzania
Equatorial Guinea
13
7
0
0
Local transmission
0
Namibia
11
3
0
0
Imported cases only
0
Eswatini
9
0
0
0
Imported cases only
2
Mozambique
8
0
0
0
Local transmission
1
Seychelles
8
1
0
0
Imported cases only
0
Gabon
7
0
1
0
Imported cases only
2
Benin
6
0
0
0
Imported cases only
3
Central African
Republic
6
0
0
0
Imported cases only
2
Eritrea
6
0
0
0
Imported cases only
3
Cabo Verde
5
0
1
0
Imported cases only
2
Chad
5
0
0
0
Imported cases only
3
Mauritania
5
0
0
0
Imported cases only
1
Zimbabwe
5
0
1
0
Local transmission
2
Gambia
3
0
1
0
Imported cases only
1
Liberia
3
0
0
0
Local transmission
8
Angola
2
0
0
0
Imported cases only
8
Guinea-Bissau
2
0
0
0
Imported cases only
4
Territories”
Reunion
207
64
0
0
Local transmission
0
Mayotte
82
32
0
0
Local transmission
0
Subtotal for all
regions
692512
58411
33099
3215
International
conveyance (Diamond
Princess)
712
0
7
0
Local transmission
14
Grand total
693224
58411
33106
3215
Numbers include both domestic and repatriated cases
+ The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on
the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
♦Case classifications are based on WHO case definitions for COVID-19.
transmission classification is based on WHO analysis of available official data and may be subject to reclassification as additional data become
available. Countries/territories/areas experiencing multiple types of transmission are classified in the highest category for which there is
evidence; they may be removed from a given category if interruption of transmission can be demonstrated. It should be noted that even within
categories, different countries/territories/areas may have differing degrees of transmission as indicated by the differing numbers of cases and
other factors. Not all locations within a given country/territory/area are equally affected.
Terms:
Community transmission is evidenced by the inability to relate confirmed cases through chains of transmission for a large number of cases, or by
increasing positive tests through sentinel samples (routine systematic testing of respiratory samples from established laboratories).
Local transmission indicates locations where the source of infection is within the reporting location.
Imported cases only indicates locations where all cases have been acquired outside the location of reporting.
Under investigation indicates locations where type of transmission has not been determined for any cases.
Interrupted transmission indicates locations where interruption of transmission has been demonstrated (details to be determined)
** "Territories" include territories, areas, overseas dependencies and other jurisdictions of similar status
[1) All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).
Due to differences in reporting methods, retrospective data consolidation, and reporting delays, the number of new cases may not always
reflect the exact difference between yesterday's and today's totals. WHO COVID-19 Situation Reports present official counts of confirmed
COVID-19 cases, thus differences between WHO reports and other sources of COVID-19 data using different inclusion criteria and different
data cutoff times are to be expected.
Cases
Figure 1. Epidemic curve of confirmed COVID-19, by date of report and WHO region through 30 March 2020
60000
50000
40000
30000
20000
10000
0
30 Dec 06 Jan 13 Jan 20 Jan 27 Jan 03 Feb 10 Feb 17 Feb 24 Feb 02 Mar 09 Mar 16 Mar 23 Mar 30 Mar
2019 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Date of report
WHO region
”1 Africa
Americas
■ Eastern Mediterranean
■ Europe
South-East Asia
i Western Pacific
Other
STRATEGIC OBJECTIVES
WHO's strategic objectives for this response are to:
• Interrupt human-to-human transmission including reducing secondary infections among close contacts
and health care workers, preventing transmission amplification events, and preventing further
international spread* *;
• Identify, isolate and care for patients early, including providing optimized care for infected patients;
• Identify and reduce transmission from the animal source;
• Address crucial unknowns regarding clinical severity, extent of transmission and infection, treatment
options, and accelerate the development of diagnostics, therapeutics and vaccines;
• Communicate critical risk and event information to all communities and counter misinformation;
• Minimize social and economic impact through multisectoral partnerships.
*This can be achieved through a combination of public health measures, such as rapid identification, diagnosis
and management of the cases, identification and follow up of the contacts, infection prevention and control in
health care settings, implementation of health measures for travelers, awareness-raising in the population and
risk communication.
PREPAREDNESS AND RESPONSE
• To view all technical guidance documents regarding COVID-19, please go to this webpage .
• WHO has developed interim guidance forjaboratory diagnosis, advice on the use of masks during home care and
in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak, clinical management,
infection prevention and control in health care settings, home care for patients with suspected novel
coronavirus, risk communication and community engagement and Global Surveillance for human infection with
novel coronavirus (2019-nCoV).
• WHO is working closely with International Air Transport Association (IATA) and have jointly developed a
guidance document to provide advice to cabin crew and airport workers, based on country queries. The
guidance can be found on the IATA webpage .
• WHO has been in regular and direct contact with Member States where cases have been reported. WHO is also
informing other countries about the situation and providing support as requested.
• WHO is working with its networks of researchers and other experts to coordinate global work on surveillance,
epidemiology, mathematical modelling, diagnostics and virology, clinical care and treatment, infection
prevention and control, and risk communication. WHO has issued interim guidance for countries, which are
updated regularly.
• WHO has prepared a disease commodity package that includes an essential list of biomedical equipment,
medicines and supplies necessary to care for patients with 2019-nCoV.
• WHO has provided recommendations to reduce risk of transmission from animals to humans .
• WHO has published an updated advice for international traffic in relation to the outbreak of the novel
coronavirus 2019-nCoV .
• WHO has activated the R&D blueprint to accelerate diagnostics, vaccines, and therapeutics.
• OpenWHO is an interactive, web-based, knowledge-transfer platform offering online courses to improve the
response to health emergencies. COVID-19 courses can be found here and courses in additional national
languages here . Specifically, WHO has developed online courses on the following topics:
o A general introduction to emerging respiratory viruses, including novel coronaviruses (available in
Arabic, Chinese, English, French, Russian, Spanish, Hindi, Indian Sign Language, Persian, Portuguese,
Serbian and Turkish);
o Clinical care for Severe Acute Respiratory Infections (available in English, French, Russian, Indonesian
and Vietnamese);
o Health and safety briefing for respiratory diseases - ePROTECT (available in Chinese, English, French,
Russian, Spanish, Indonesian and Portuguese);
o Infection Prevention and Control for Novel Coronavirus (COVID-19) (available in Chinese, English, French,
Russian, Spanish, Indonesian, Italian, Japanese, Portuguese and Serbian); and
o COVID-19 Operational Planning Guidelines and COVID-19 Partners Platform to support country
preparedness and response (available in English and coming soon in additional languages).
• WHO is providing guidance on early investigations, which are critical in an outbreak of a new virus. The data
collected from the protocols can be used to refine recommendations for surveillance and case definitions, to
characterize the key epidemiological transmission features of COVID-19, help understand spread, severity,
spectrum of disease, impact on the community and to inform operational models for implementation of
countermeasures such as case isolation, contact tracing and isolation. Several protocols are available here . One
such protocol is for the investigation of early COVID-19 cases and contacts (the " First Few X (FFX) Cases and
contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection "). The protocol is designed to
gain an early understanding of the key clinical, epidemiological and virological characteristics of the first cases of
COVID-19 infection detected in any individual country, to inform the development and updating of public health
guidance to manage cases and reduce the potential spread and impact of infection.
RECOMMENDATIONS AND ADVICE FOR THE PUBLIC
If you are not in an area where COVID-19 is spreading or have not travelled from an area where COVID-19 is
spreading or have not been in contact with an infected patient, your risk of infection is low. It is understandable that
you may feel anxious about the outbreak. Get the facts from reliable sources to help you accurately determine your
risks so that you can take reasonable precautions (see Frequently Asked Questions ). Seek guidance from WHO, your
healthcare provider, your national public health authority or your employer for accurate information on COVID-19
and whether COVID-19 is circulating where you live. It is important to be informed of the situation and take
appropriate measures to protect yourself and your family (see Protection measures for everyone) .
If you are in an area where there are cases of COVID-19 you need to take the risk of infection seriously. Follow the
advice of WHO and guidance issued by national and local health authorities. For most people, COVID-19 infection
will cause mild illness however, it can make some people very ill and, in some people, it can be fatal. Older people,
and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or
diabetes) are at risk for severe disease (See Protection measures for persons who are in or have recently visited (past
14 days) areas where COVID-19 is spreading ).
CASE DEFINITIONS
WHO periodically updates the Global Surveillance for human infection with coronavirus disease (COVID-19)
document which includes case definitions.
For easy reference, case definitions are included below.
Suspect case
A. A patient with acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g., cough,
shortness of breath), AND a history of travel to or residence in a location reporting community transmission of
COVID-19 disease during the 14 days prior to symptom onset.
OR
B. A patient with any acute respiratory illness AND having been in contact with a confirmed or probable COVID-19
case (see definition of contact) in the last 14 days prior to symptom onset;
OR
C. A patient with severe acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g.,
cough, shortness of breath; AND requiring hospitalization) AND in the absence of an alternative diagnosis that
fully explains the clinical presentation.
Probable case
A. A suspect case for whom testing for the COVID-19 virus is inconclusive.
a. Inconclusive being the result of the test reported by the laboratory.
OR
B. A suspect case for whom testing could not be performed for any reason.
Confirmed case
A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.
• Technical guidance for laboratory testing can be found here .
Definition of contact
A contact is a person who experienced any one of the following exposures during the 2 days before and the 14 days
after the onset of symptoms of a probable or confirmed case:
1. Face-to-face contact with a probable or confirmed case within 1 meter and for more than 15 minutes;
2. Direct physical contact with a probable or confirmed case;
3. Direct care for a patient with probable or confirmed COVID-19 disease without using proper personal
protective equipment 1 ; OR
4. Other situations as indicated by local risk assessments.
Note: for confirmed asymptomatic cases, the period of contact is measured as the 2 days before through the 14 days
after the date on which the sample was taken which led to confirmation.
1 World Health Organization. Infection prevention and control during health care when COVID-19 is suspected
https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-
infection-is-suspected-20200125
